{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:55:00Z","timestamp":1790985300063,"version":"4.1.0"},"reference-count":145,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T00:00:00Z","timestamp":1647993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Italian Ministry of Health","award":["Ricerca Corrente and and 5 \u00d7 1000 funds"],"award-info":[{"award-number":["Ricerca Corrente and and 5 \u00d7 1000 funds"]}]},{"name":"Alleanza contro il Cancro (ACC)","award":["WP5"],"award-info":[{"award-number":["WP5"]}]},{"name":"EU-LAC Health framework","award":["HeadLace"],"award-info":[{"award-number":["HeadLace"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Head and Neck Squamous Cell Carcinoma (HNSCC) is a highly heterogeneous group of tumors characterized by an incidence of 650,000 new cases and 350,000 deaths per year worldwide and a male to female ratio of 3:1. The main risk factors are alcohol and tobacco consumption and Human Papillomavirus (HPV) infections. HNSCC cases are divided into two subgroups, the HPV-negative (HPV\u2212) and the HPV-positive (HPV+) which have different clinicopathological and molecular profiles. However, patients are still treated with the same therapeutic regimens. It is thus of utmost importance to characterize the molecular mechanisms underlying these differences to find new biomarkers and novel therapeutic targets towards personalized therapies. Epigenetic alterations are a hallmark of cancer and can be exploited as both promising biomarkers and potential new targets. E6 and E7 HPV oncoviral proteins besides targeting p53 and pRb, impair the expression and the activity of several epigenetic regulators. While alterations in DNA methylation patterns have been well described in HPV+ and HPV\u2212 HNSCC, accurate histone post-translational modifications (hPTMs) characterization is still missing. Herein, we aim to provide an updated overview on the impact of HPV on the hPTMs landscape in HNSCC. Moreover, we will also discuss the sex and gender bias in HNSCC and how the epigenetic machinery could be involved in this process, and the importance of taking into account sex and\/or gender also in this field.<\/jats:p>","DOI":"10.3390\/ijms23073483","type":"journal-article","created":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T12:20:25Z","timestamp":1648038025000},"page":"3483","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["High Risk-Human Papillomavirus in HNSCC: Present and Future Challenges for Epigenetic Therapies"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6298-0495","authenticated-orcid":false,"given":"Lavinia","family":"Ghiani","sequence":"first","affiliation":[{"name":"Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, IEO Campus, Via Adamello 16, 20139 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9721-0850","authenticated-orcid":false,"given":"Susanna","family":"Chiocca","sequence":"additional","affiliation":[{"name":"Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, IEO Campus, Via Adamello 16, 20139 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,3,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrc.2018.11","article-title":"The molecular landscape of head and neck cancer","volume":"18","author":"Leemans","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/annonc\/mdz084","article-title":"Head and neck cancer prevention: From primary prevention to impact of clinicians on reducing burden","volume":"30","author":"Hashim","year":"2019","journal-title":"Ann. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41416-019-0602-7","article-title":"Human papillomavirus as a driver of head and neck cancers","volume":"122","author":"Sabatini","year":"2020","journal-title":"Br. J. Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1158\/1541-7786.MCR-18-0056","article-title":"Comprehensive Genomic Profiling of Patient-matched Head and Neck Cancer Cells: A Preclinical Pipeline for Metastatic and Recurrent Disease","volume":"16","author":"Nisa","year":"2018","journal-title":"Mol. Cancer Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","article-title":"Head and neck squamous cell carcinoma","volume":"6","author":"Johnson","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Lechner, M., Liu, J., Masterson, L., and Fenton, T.R. (2022). HPV-associated oropharyngeal cancer: Epidemiology, molecular biology and clinical management. Nat. Rev. Clin. Oncol., Epub ahead of print.","DOI":"10.1038\/s41571-022-00603-7"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3322\/caac.21388","article-title":"The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/cjp2.111","article-title":"Current status of clinical testing for human papillomavirus in oropharyngeal squamous cell carcinoma","volume":"4","author":"Kim","year":"2018","journal-title":"J. Pathol. Clin. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"djv403","DOI":"10.1093\/jnci\/djv403","article-title":"HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients","volume":"108","author":"Alemany","year":"2016","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Tagliabue, M., Mena, M., Maffini, F., Gheit, T., Blasco, B.Q., Holzinger, D., Tous, S., Scelsi, D., Riva, D., and Grosso, E. (2020). Role of Human Papillomavirus Infection in Head and Neck Cancer in Italy: The HPV-AHEAD Study. Cancers, 12.","DOI":"10.3390\/cancers12123567"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/cncr.22963","article-title":"Trends in head and neck cancer incidence in relation to smoking prevalence: An emerging epidemic of human papillomavirus-associated cancers?","volume":"110","author":"Sturgis","year":"2007","journal-title":"Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41571-019-0227-z","article-title":"The changing therapeutic landscape of head and neck cancer","volume":"16","author":"Cramer","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"105168","DOI":"10.1016\/j.oraloncology.2020.105168","article-title":"Human Papilloma Virus vaccine and prevention of head and neck cancer, what is the current evidence?","volume":"115","author":"Diana","year":"2021","journal-title":"Oral Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Powell, S.F., Vu, L., Spanos, W.C., and Pyeon, D. (2021). The Key Differences between Human Papillomavirus-Positive and -Negative Head and Neck Cancers: Biological and Clinical Implications. Cancers, 13.","DOI":"10.3390\/cancers13205206"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nature14129","article-title":"Comprehensive genomic characterization of head and neck squamous cell carcinomas","volume":"517","year":"2015","journal-title":"Nature"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"24927","DOI":"10.1038\/srep24927","article-title":"Integrative Genomics and Transcriptomics Analysis Reveals Potential Mechanisms for Favorable Prognosis of Patients with HPV-Positive Head and Neck Carcinomas","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1158\/1078-0432.CCR-05-2017","article-title":"Gene Expression Differences Associated with Human Papillomavirus Status in Head and Neck Squamous Cell Carcinoma","volume":"12","author":"Slebos","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Castilho, R.M., Squarize, C.H., and Almeida, L.O. (2017). Epigenetic Modifications and Head and Neck Cancer: Implications for Tumor Progression and Resistance to Therapy. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18071506"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1177\/0022034518816947","article-title":"Impact of Epigenetic Regulation on Head and Neck Squamous Cell Carcinoma","volume":"98","author":"Bais","year":"2019","journal-title":"J. Dent. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.5858\/arpa.2014-0554-RA","article-title":"Epigenetic Mechanisms of Human Papillomavirus\u2014Associated Head and Neck Cancer","volume":"139","author":"Anayannis","year":"2015","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10528-019-09941-1","article-title":"Epigenetic Modifications in Head and Neck Cancer","volume":"58","author":"Strzelczyk","year":"2020","journal-title":"Biochem. Genet."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Richards, K.L., Zhang, B., Baggerly, K.A., Colella, S., Lang, J.C., Schuller, D.E., and Krahe, R. (2009). Genome-Wide Hypomethylation in Head and Neck Cancer Is More Pronounced in HPV-Negative Tumors and Is Associated with Genomic Instability. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0004941"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s11912-014-0402-4","article-title":"The Burden of HPV-Associated Anogenital Cancers","volume":"16","author":"Wakeham","year":"2014","journal-title":"Curr. Oncol. Rep."},{"key":"ref_25","first-page":"3","article-title":"HPV in Head and Neck Cancer\u201430 Years of History","volume":"206","author":"Rautava","year":"2016","journal-title":"HPV Infect. Head Neck Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Yeo-Teh, N.S.L., Ito, Y., and Jha, S. (2018). High-Risk Human Papillomaviral Oncogenes E6 and E7 Target Key Cellular Pathways to Achieve Oncogenesis. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19061706"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1200\/JCO.2015.61.6995","article-title":"Epidemiology of Human Papillomavirus\u2013Positive Head and Neck Squamous Cell Carcinoma","volume":"33","author":"Gillison","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.mrrev.2016.09.006","article-title":"Human papillomaviruses in epigenetic regulations","volume":"772","author":"Poreba","year":"2017","journal-title":"Mutat. Res. Mutat. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cell.2012.06.013","article-title":"Cancer Epigenetics: From Mechanism to Therapy","volume":"150","author":"Dawson","year":"2012","journal-title":"Cell"},{"key":"ref_30","first-page":"e11725","article-title":"Advances in Epigenetic Cancer Therapeutics","volume":"12","author":"Hillyar","year":"2020","journal-title":"Cureus"},{"key":"ref_31","first-page":"1","article-title":"The cancer driver genes IDH1\/2, JARID1C\/ KDM5C, and UTX\/ KDM6A: Crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism","volume":"51","author":"Chang","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Togni, L., Mascitti, M., Sartini, D., Campagna, R., Pozzi, V., Salvolini, E., Offidani, A., Santarelli, A., and Emanuelli, M. (2021). Nicotinamide N-Methyltransferase in Head and Neck Tumors: A Comprehensive Review. Biomolecules, 11.","DOI":"10.3390\/biom11111594"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/nchembio.1204","article-title":"NNMT promotes epigenetic remodeling in cancer by creating a metabolic methylation sink","volume":"9","author":"Ulanovskaya","year":"2013","journal-title":"Nat. Chem. Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00784-018-2497-8","article-title":"Overexpression of nicotinamide N-methyltransferase in HSC-2 OSCC cell line: Effect on apoptosis and cell proliferation","volume":"23","author":"Seta","year":"2019","journal-title":"Clin. Oral Investig."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/iub.2265","article-title":"Cancer stem cell enrichment is associated with enhancement of nicotinamide N-methyltransferase expression","volume":"72","author":"Pozzi","year":"2020","journal-title":"IUBMB Life"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1111\/pcmr.12993","article-title":"Nicotinamide N-methyltransferase gene silencing enhances chemosensitivity of melanoma cell lines","volume":"34","author":"Campagna","year":"2021","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1126\/science.1073096","article-title":"Addiction to Oncogenes\u2014The Achilles Heal of Cancer","volume":"297","author":"Weinstein","year":"2002","journal-title":"Science"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nrg.2016.93","article-title":"Targeting the cancer epigenome for therapy","volume":"17","author":"Jones","year":"2016","journal-title":"Nat. Rev. Genet."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41568-019-0109-9","article-title":"Epigenetic therapy in immune-oncology","volume":"19","author":"Jones","year":"2019","journal-title":"Nat. Cancer"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Burkitt, K., and Saloura, V. (2021). Epigenetic Modifiers as Novel Therapeutic Targets and a Systematic Review of Clinical Studies Investigating Epigenetic Inhibitors in Head and Neck Cancer. Cancers, 13.","DOI":"10.3390\/cancers13205241"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/nsmb840","article-title":"Intragenic DNA methylation alters chromatin structure and elongation efficiency in mammalian cells","volume":"11","author":"Lorincz","year":"2004","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nrc3130","article-title":"A decade of exploring the cancer epigenome\u2014Biological and translational implications","volume":"11","author":"Baylin","year":"2011","journal-title":"Nat. Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1158\/0008-5472.CAN-04-2158","article-title":"Regulation of DNA methyltransferase 1 by the pRb\/E2F1 pathway","volume":"65","author":"McCabe","year":"2005","journal-title":"Cancer Res."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Camuzi, D., Buexm, L., Louren\u00e7o, S., Esposti, D., Cuenin, C., Lopes, M., Manara, F., Talukdar, F., Herceg, Z., and Pinto, L.R. (2021). HPV Infection Leaves a DNA Methylation Signature in Oropharyngeal Cancer Affecting Both Coding Genes and Transposable Elements. Cancers, 13.","DOI":"10.3390\/cancers13143621"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13039-019-0447-z","article-title":"Head and neck cancer: Searching for genomic and epigenetic biomarkers in body fluids\u2014The state of art","volume":"12","author":"Ribeiro","year":"2019","journal-title":"Mol. Cytogenet."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nrg.2016.59","article-title":"The molecular hallmarks of epigenetic control","volume":"17","author":"Allis","year":"2016","journal-title":"Nat. Rev. Genet."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/ng.154","article-title":"Combinatorial patterns of histone acetylations and methylations in the human genome","volume":"40","author":"Wang","year":"2008","journal-title":"Nat. Genet."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/s41594-019-0298-7","article-title":"Histone lysine methyltransferases in biology and disease","volume":"26","author":"Husmann","year":"2019","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/bfgp\/elt002","article-title":"Proteomics in epigenetics: New perspectives for cancer research","volume":"12","author":"Bartke","year":"2013","journal-title":"Brief. Funct. Genom."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.dib.2016.02.028","article-title":"Mass-spectrometry analysis of histone post-translational modifications in pathology tissue using the PAT-H-MS approach","volume":"7","author":"Noberini","year":"2016","journal-title":"Data Brief."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13148-021-01120-7","article-title":"Spatial epi-proteomics enabled by histone post-translational modification analysis from low-abundance clinical samples","volume":"13","author":"Noberini","year":"2021","journal-title":"Clin. Epigenetics"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Romanowska, K., Sobecka, A., Raw\u0142uszko-Wieczorek, A.A., Suchorska, W.M., and Golusi\u0144ski, W. (2020). Head and Neck Squamous Cell Carcinoma: Epigenetic Landscape. Diagnostics, 11.","DOI":"10.3390\/diagnostics11010034"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Noberini, R., Restellini, C., Savoia, E.O., Raimondi, F., Ghiani, L., Jodice, M.G., Bertalot, G., Bonizzi, G., Capra, M., and Maffini, F.A. (2019). Profiling of Epigenetic Features in Clinical Samples Reveals Novel Widespread Changes in Cancer. Cancers, 11.","DOI":"10.3390\/cancers11050723"},{"key":"ref_54","first-page":"S65","article-title":"Epigenetic differences between human papillomavirus-positive and -negative oropharyngeal squamous cell carcinomas","volume":"41","author":"Biron","year":"2012","journal-title":"J. Otolaryngol.-Head Neck Surg."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1073\/pnas.1009933108","article-title":"Human papillomavirus E7 oncoprotein induces KDM6A and KDM6B histone demethylase expression and causes epigenetic reprogramming","volume":"108","author":"Crum","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"10999","DOI":"10.1128\/JVI.00160-11","article-title":"Evidence for alteration of EZH2, BMI1, and KDM6A and epigenetic reprogramming in human papillomavirus type 16 E6\/E7-expressing keratinocytes","volume":"85","author":"Hyland","year":"2011","journal-title":"J. Virol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"72564","DOI":"10.18632\/oncotarget.19885","article-title":"Human papillomavirus dysregulates the cellular apparatus controlling the methylation status of H3K27 in different human cancers to consistently alter gene expression regardless of tissue of origin","volume":"8","author":"Gameiro","year":"2017","journal-title":"Oncotarget"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"9964","DOI":"10.1158\/0008-5472.CAN-08-1134","article-title":"Activation of the Enhancer of Zeste Homologue 2 Gene by the Human Papillomavirus E7 Oncoprotein","volume":"68","author":"Holland","year":"2008","journal-title":"Cancer Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1158\/1078-0432.CCR-12-2505","article-title":"Dysregulation of the Repressive H3K27 Trimethylation Mark in Head and Neck Squamous Cell Carcinoma Contributes to Dysregulated Squamous Differentiation","volume":"19","author":"Gannon","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1158\/1541-7786.MCR-14-0292-T","article-title":"WHSC1 Promotes Oncogenesis through Regulation of NIMA-Related Kinase-7 in Squamous Cell Carcinoma of the Head and Neck","volume":"13","author":"Saloura","year":"2015","journal-title":"Mol. Cancer Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"6538","DOI":"10.1158\/0008-5472.CAN-17-0833","article-title":"Integrated Analysis of Whole-Genome ChIP-Seq and RNA-Seq Data of Primary Head and Neck Tumor Samples Associates HPV Integration Sites with Open Chromatin Marks","volume":"77","author":"Kelley","year":"2017","journal-title":"Cancer Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1080\/15592294.2020.1741757","article-title":"Chromatin structure regulates cancer-specific alternative splicing events in primary HPV-related oropharyngeal squamous cell carcinoma","volume":"15","author":"Guo","year":"2020","journal-title":"Epigenetics"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1093\/emboj\/18.18.5061","article-title":"The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300","volume":"18","author":"Patel","year":"1999","journal-title":"EMBO J."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"6209","DOI":"10.1128\/JVI.73.8.6209-6219.1999","article-title":"The human papillomavirus type 16 E6 oncoprotein can down-regulate p53 activity by targeting the transcriptional coactivator CBP\/p300","volume":"73","author":"Zimmermann","year":"1999","journal-title":"J. Virol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1016\/j.jmb.2014.10.021","article-title":"The High-Risk HPV16 E7 Oncoprotein Mediates Interaction between the Transcriptional Coactivator CBP and the Retinoblastoma Protein pRb","volume":"426","author":"Jansma","year":"2014","journal-title":"J. Mol. Biol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.1038\/sj.onc.1206562","article-title":"Interaction of the HPV E7 proteins with the pCAF acetyltransferase","volume":"22","author":"Avvakumov","year":"2003","journal-title":"Oncogene"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.gde.2004.02.009","article-title":"The highly conserved and multifunctional NuA4 HAT complex","volume":"14","author":"Doyon","year":"2004","journal-title":"Curr. Opin. Genet. Dev."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.molcel.2010.05.020","article-title":"Destabilization of TIP60 by Human Papillomavirus E6 Results in Attenuation of TIP60-Dependent Transcriptional Regulation and Apoptotic Pathway","volume":"38","author":"Jha","year":"2010","journal-title":"Mol. Cell"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"194626","DOI":"10.1016\/j.bbagrm.2020.194626","article-title":"GCN5 acetyltransferase in cellular energetic and metabolic processes","volume":"1864","author":"Mutlu","year":"2020","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"9411","DOI":"10.1074\/jbc.M809617200","article-title":"The Gcn5 Bromodomain of the SAGA Complex Facilitates Cooperative and Cross-tail Acetylation of Nucleosomes","volume":"284","author":"Li","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1158\/0008-5472.CAN-10-2626","article-title":"Human Papillomavirus E7 Enhances Hypoxia-Inducible Factor 1\u2013Mediated Transcription by Inhibiting Binding of Histone Deacetylases","volume":"71","author":"Bodily","year":"2011","journal-title":"Cancer Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"6764","DOI":"10.1074\/jbc.275.10.6764","article-title":"Inactivation of Interferon Regulatory Factor-1 Tumor Suppressor Protein by HPV E7 Oncoprotein","volume":"275","author":"Park","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.molcel.2004.08.031","article-title":"Human SirT1 Interacts with Histone H1 and Promotes Formation of Facultative Heterochromatin","volume":"16","author":"Vaquero","year":"2004","journal-title":"Mol. Cell"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"316","DOI":"10.18632\/aging.100028","article-title":"Oncogenic viral protein HPV E7 up-regulates the SIRT1 longevity protein in human cervical cancer cells","volume":"1","author":"Allison","year":"2009","journal-title":"Aging"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e00102-17","DOI":"10.1128\/JVI.00102-17","article-title":"The Deacetylase SIRT1 Regulates the Replication Properties of Human Papillomavirus 16 E1 and E2","volume":"91","author":"Das","year":"2017","journal-title":"J. Virol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"7871","DOI":"10.1038\/sj.onc.1206896","article-title":"Interaction between the HPV E7 oncoprotein and the transcriptional coactivator p300","volume":"22","author":"Bernat","year":"2003","journal-title":"Oncogene"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"5333","DOI":"10.1111\/jcmm.13806","article-title":"The lysine acetyltransferase GCN5 contributes to human papillomavirus oncoprotein E7-induced cell proliferation via up-regulating E2F1","volume":"22","author":"Qiao","year":"2018","journal-title":"J. Cell. Mol. Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.virol.2004.08.009","article-title":"Human papillomavirus type 16 E7 protein increases acetylation of histone H3 in human foreskin keratinocytes","volume":"329","author":"Zhang","year":"2004","journal-title":"Virology"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Wongjampa, W., Ekalaksananan, T., Chopjitt, P., Chuerduangphui, J., Kleebkaow, P., Patarapadungkit, N., and Pientong, C. (2018). Suppression of miR-22, a tumor suppressor in cervical cancer, by human papillomavirus 16 E6 via a p53\/miR-22\/HDAC6 pathway. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0206644"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1002\/cncr.26575","article-title":"Up-regulation of enhancer of zeste homolog 2 is associated positively with cyclin D1 overexpression and poor clinical outcome in head and neck squamous cell carcinoma","volume":"118","author":"Cao","year":"2012","journal-title":"Cancer"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.oraloncology.2015.11.002","article-title":"EZH2 is associated with poor prognosis in head-and-neck squamous cell carcinoma via regulating the epithelial-to-mesenchymal transition and chemosensitivity","volume":"52","author":"Chang","year":"2016","journal-title":"Oral Oncol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"33720","DOI":"10.18632\/oncotarget.5606","article-title":"Targeting EZH2 regulates tumor growth and apoptosis through modulating mitochondria dependent cell-death pathway in HNSCC","volume":"6","author":"Zhou","year":"2015","journal-title":"Oncotarget"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s40463-016-0168-9","article-title":"Investigation of EZH2 pathways for novel epigenetic treatment strategies in oropharyngeal cancer","volume":"45","author":"Idris","year":"2016","journal-title":"J. Otolaryngol.-Head Neck Surg."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"e01812-19","DOI":"10.1128\/JVI.01812-19","article-title":"Human Papillomavirus E7 Oncoprotein Subverts Host Innate Immunity via SUV39H1-Mediated Epigenetic Silencing of Immune Sensor Genes","volume":"94","author":"Cigno","year":"2020","journal-title":"J. Virol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13027-021-00347-6","article-title":"Low expression of NSD1, NSD2, and NSD3 define a subset of human papillomavirus-positive oral squamous carcinomas with unfavorable prognosis","volume":"16","author":"Gameiro","year":"2021","journal-title":"Infect. Agents Cancer"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1038\/onc.2011.415","article-title":"The HPV E6 oncoprotein targets histone methyltransferases for modulating specific gene transcription","volume":"31","author":"Hsu","year":"2012","journal-title":"Oncogene"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1002\/jcp.27080","article-title":"HPV16 E7-induced upregulation of KDM2A promotes cervical cancer progression by regulating miR-132\u2013radixin pathway","volume":"234","author":"Ou","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1038\/s41388-017-0083-1","article-title":"HPV16 E6 and E7 upregulate the histone lysine demethylase KDM2B through the c-MYC\/miR-146a-5p axys","volume":"37","author":"Peta","year":"2018","journal-title":"Oncogene"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"112277","DOI":"10.1016\/j.yexcr.2020.112277","article-title":"Human papillomavirus type 16 E7 oncoprotein-induced upregulation of lysine-specific demethylase 5A promotes cervical cancer progression by regulating the microRNA-424\u20135p\/suppressor of zeste 12 pathway","volume":"396","author":"Liu","year":"2020","journal-title":"Exp. Cell Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1158\/0008-5472.CAN-17-2118","article-title":"E6 Protein Expressed by High-Risk HPV Activates Super-Enhancers of the EGFR and c-MET Oncogenes by Destabilizing the Histone Demethylase KDM5C","volume":"78","author":"Chen","year":"2018","journal-title":"Cancer Res."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.virol.2014.08.022","article-title":"SMCX and components of the TIP60 complex contribute to E2 regulation of the HPV E6\/E7 promoter","volume":"468\u2013470","author":"Smith","year":"2014","journal-title":"Virology"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"16175","DOI":"10.1073\/pnas.1310432110","article-title":"Tumor suppressor p16 INK4A is necessary for survival of cervical carcinoma cell lines","volume":"110","author":"Park","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1186\/s12935-020-01380-y","article-title":"SUV39H1-DNMT3A-mediated epigenetic regulation of Tim-3 and galectin-9 in the cervical cancer","volume":"20","author":"Zhang","year":"2020","journal-title":"Cancer Cell Int."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.oraloncology.2018.04.014","article-title":"The role of protein methyltransferases as potential novel therapeutic targets in squamous cell carcinoma of the head and neck","volume":"81","author":"Saloura","year":"2018","journal-title":"Oral Oncol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.str.2019.01.011","article-title":"Set7 Is a H3K37 Methyltransferase in Schizosaccharomyces pombe and Is Required for Proper Gametogenesis","volume":"27","author":"Shen","year":"2019","journal-title":"Structure"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1101\/gad.1315905","article-title":"Specificity and Mechanism of the Histone Methyltransferase Pr-Set7","volume":"19","author":"Xiao","year":"2005","journal-title":"Genes Dev."},{"key":"ref_97","first-page":"2222","article-title":"The critical role of histone lysine demethylase KDM2B in cancer","volume":"10","author":"Yan","year":"2018","journal-title":"Am. J. Transl. Res."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3390\/cancers3011383","article-title":"Epigenetic Regulation by Lysine Demethylase 5 (KDM5) Enzymes in Cancer","volume":"3","author":"Blair","year":"2011","journal-title":"Cancers"},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Jose, A., Shenoy, G.G., Rodrigues, G.S., Kumar, N.A.N., Munisamy, M., Thomas, L., Kolesar, J., Rai, G., Rao, P.P.N., and Rao, M. (2020). Histone Demethylase KDM5B as a Therapeutic Target for Cancer Therapy. Cancers, 12.","DOI":"10.3390\/cancers12082121"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"198","DOI":"10.7150\/jca.22145","article-title":"KDM5B overexpression predicts a poor prognosis in patients with squamous cell carcinoma of the head and neck","volume":"9","author":"Huang","year":"2018","journal-title":"Cancer"},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Wu, L., Cao, J., Cai, W.L., Lang, S.M., Horton, J.R., Jansen, D.J., Liu, Z.Z., Chen, J.F., Zhang, M., and Mott, B.T. (2018). KDM5 histone demethylases repress immune response via suppression of STING. PLoS Biol., 16.","DOI":"10.1371\/journal.pbio.2006134"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/ng.3726","article-title":"Tumor-suppressor genes that escape from X-inactivation contribute to cancer sex bias","volume":"49","author":"Dunford","year":"2016","journal-title":"Nat. Genet."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"eaar5598","DOI":"10.1126\/sciadv.aar5598","article-title":"X chromosome protects against bladder cancer in females via a KDM6A -dependent epigenetic mechanism","volume":"4","author":"Kaneko","year":"2018","journal-title":"Sci. Adv."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1158\/1078-0432.CCR-17-1573","article-title":"BAP1 Is a Novel Target in HPV-Negative Head and Neck Cancer","volume":"24","author":"Liu","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1158\/2159-8290.CD-17-1018","article-title":"Multiple Routes to Oncogenesis Are Promoted by the Human Papillomavirus\u2014Host Protein Network","volume":"8","author":"Eckhardt","year":"2018","journal-title":"Cancer Discov."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.1158\/1078-0432.CCR-16-0323","article-title":"Subtypes of HPV-Positive Head and Neck Cancers Are Associated with HPV Characteristics, Copy Number Alterations, PIK3CA Mutation, and Pathway Signatures","volume":"22","author":"Zhang","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"e124762","DOI":"10.1172\/jci.insight.124762","article-title":"Variations in HPV function are associated with survival in squamous cell carcinoma","volume":"4","author":"Rao","year":"2019","journal-title":"JCI Insight"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1200\/JCO.20.00056","article-title":"De-Escalation After De-ESCALATE and RTOG 1016: A Head and Neck Cancer InterGroup Framework for Future De-Escalation Studies","volume":"38","author":"Mehanna","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/onco.13742","article-title":"De-Escalated Adjuvant Therapy After Transoral Robotic Surgery for Human Papillomavirus-Related Oropharyngeal Carcinoma: The Sinai Robotic Surgery (SIRS) Trial","volume":"26","author":"Miles","year":"2021","journal-title":"Oncologist"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.7150\/ijbs.58077","article-title":"Therapeutic strategies of different HPV status in Head and Neck Squamous Cell Carcinoma","volume":"17","author":"Sun","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1056\/NEJMra1715715","article-title":"Head and Neck Cancer","volume":"382","author":"Chow","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Cristina, V., Herrera-G\u00f3mez, R.G., Szturz, P., Espeli, V., and Siano, M. (2019). Immunotherapies and Future Combination Strategies for Head and Neck Squamous Cell Carcinoma. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20215399"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"106002","DOI":"10.1016\/j.biocel.2021.106002","article-title":"The biology of combination immunotherapy in recurrent metastatic head and neck cancer","volume":"136","author":"Yuan","year":"2021","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41571-019-0266-5","article-title":"The emerging role of epigenetic therapeutics in immuno-oncology","volume":"17","author":"Topper","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10555-020-09944-0","article-title":"Epigenetic modulation of immunotherapy and implications in head and neck cancer","volume":"40","author":"Zhou","year":"2021","journal-title":"Cancer Metastasis Rev."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(19)32591-7","article-title":"Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): A randomised, open-label, phase 3 study","volume":"394","author":"Burtness","year":"2019","journal-title":"Lancet"},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Li, X., Fang, Q., Du, W., Zhang, X., Dai, L., and Qiao, Y. (2021). Induction chemotherapy combined with immunotherapy in locally advanced head and neck squamous cell carcinoma. BMC Cancer, 21.","DOI":"10.1186\/s12885-021-08373-8"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"727433","DOI":"10.3389\/fonc.2021.727433","article-title":"Immunotherapy for Head and Neck Cancer: A Paradigm Shift From Induction Chemotherapy to Neoadjuvant Immunotherapy","volume":"11","author":"Shibata","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"864","DOI":"10.20892\/j.issn.2095-3941.2020.0370","article-title":"Biological and clinical aspects of HPV-related cancers","volume":"17","author":"Szymonowicz","year":"2020","journal-title":"Cancer Biol. Med."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"7276","DOI":"10.1158\/1078-0432.CCR-17-1438","article-title":"Demethylation Therapy as a Targeted Treatment for Human Papillomavirus\u2013Associated Head and Neck Cancer","volume":"23","author":"Biktasova","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Viet, C.T., Dang, N., Achdjian, S., Ye, Y., Katz, S.G., and Schmidt, B.L. (2014). Decitabine Rescues Cisplatin Resistance in Head and Neck Squamous Cell Carcinoma. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0112880"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/s41416-019-0394-9","article-title":"Synergistic antitumour activity of HDAC inhibitor SAHA and EGFR inhibitor gefitinib in head and neck cancer: A key role for DeltaNp63alpha","volume":"120","author":"Citro","year":"2019","journal-title":"Br. J. Cancer"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"73372","DOI":"10.18632\/oncotarget.19637","article-title":"Inhibition of LSD1 epigenetically attenuates oral cancer growth and metastasis","volume":"8","author":"AlSaqer","year":"2017","journal-title":"Oncotarget"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1158\/1078-0432.CCR-19-1351","article-title":"Targeting EZH2 Enhances Antigen Presentation, Antitumor Immunity, and Circumvents Anti-PD-1 Resistance in Head and Neck Cancer","volume":"26","author":"Zhou","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Lopes-Ramos, C.M., Quackenbush, J., and DeMeo, D.L. (2020). Genome-Wide Sex and Gender Differences in Cancer. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.597788"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.trecan.2022.01.013","article-title":"The spectrum of sex differences in cancer","volume":"8","author":"Rubin","year":"2022","journal-title":"Trends Cancer"},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Irelli, A., Sirufo, M.M., D\u2019Ugo, C., Ginaldi, L., and De Martinis, M. (2020). Sex and Gender Influences on Cancer Immunotherapy Response. Biomedicines, 8.","DOI":"10.3390\/biomedicines8070232"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.1128\/MCB.00601-10","article-title":"Unbiased, Genome-Wide In Vivo Mapping of Transcriptional Regulatory Elements Reveals Sex Differences in Chromatin Structure Associated with Sex-Specific Liver Gene Expression","volume":"30","author":"Ling","year":"2010","journal-title":"Mol. Cell. Biol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1089\/jwh.2019.8247","article-title":"Sex as a Biological Variable: A 5-Year Progress Report and Call to Action","volume":"29","author":"Arnegard","year":"2020","journal-title":"J. Women\u2019s Health"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.21873\/anticanres.13299","article-title":"HPV Status and Survival in Non-Oropharyngeal Squamous Cell Carcinoma of the Head and Neck","volume":"39","author":"Wookey","year":"2019","journal-title":"Anticancer Res."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.ccell.2016.04.001","article-title":"Comprehensive Characterization of Molecular Differences in Cancer between Male and Female Patients","volume":"29","author":"Yuan","year":"2016","journal-title":"Cancer Cell"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/cam4.1136","article-title":"Hormone factors play a favorable role in female head and neck cancer risk","volume":"6","author":"Hashim","year":"2017","journal-title":"Cancer Med."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"55511","DOI":"10.18632\/oncotarget.19224","article-title":"Meta-analysis of microRNAs expression in head and neck cancer: Uncovering association with outcome and mechanisms","volume":"8","author":"Lubov","year":"2017","journal-title":"Oncotarget"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.21873\/anticanres.13593","article-title":"Androgen Receptor as a Biomarker of Oral Squamous Cell Carcinoma Progression Risk","volume":"39","author":"Fucic","year":"2019","journal-title":"Anticancer Res."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"6529","DOI":"10.1158\/1078-0432.CCR-09-0862","article-title":"Cross-Talk between Estrogen Receptor and Epidermal Growth Factor Receptor in Head and Neck Squamous Cell Carcinoma","volume":"15","author":"Egloff","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1596\/neo.12300","article-title":"Degradation of Epidermal Growth Factor Receptor Mediates Dasatinib-Induced Apoptosis in Head and Neck Squamous Cell Carcinoma Cells","volume":"14","author":"Lin","year":"2012","journal-title":"Neoplasia"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/ijc.32500","article-title":"Expression of estrogen receptor alpha is associated with pathogenesis and prognosis of human papillomavirus-positive oropharyngeal cancer","volume":"145","author":"Kano","year":"2019","journal-title":"Int. J. Cancer"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.3390\/cancers3021691","article-title":"Epigenetics of Estrogen Receptor Signaling: Role in Hormonal Cancer Progression and Therapy","volume":"3","author":"Mann","year":"2011","journal-title":"Cancers"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.tig.2011.01.004","article-title":"Epigenetic regulation of autosomal gene expression by sex chromosomes","volume":"27","author":"Wijchers","year":"2011","journal-title":"Trends Genet."},{"key":"ref_141","first-page":"1400","article-title":"Gonadoblastoma: Molecular definition of the susceptibility region on the Y chromosome","volume":"57","author":"Tsuchiya","year":"1995","journal-title":"Am. J. Hum. Genet."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/hed.25537","article-title":"Association between loss of Y chromosome and poor prognosis in male head and neck squamous cell carcinoma","volume":"41","author":"Hollows","year":"2019","journal-title":"Head Neck"},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Fang, H., Disteche, C.M., and Berletch, J.B. (2019). X Inactivation and Escape: Epigenetic and Structural Features. Front. Cell Dev. Biol., 7.","DOI":"10.3389\/fcell.2019.00219"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1158\/1078-0432.CCR-10-2316","article-title":"Reduced p21(WAF1\/CIP1) via alteration of p53-DDX3 pathway is associated with poor relapse-free survival in early-stage human papillomavirus-associated lung cancer","volume":"17","author":"Wu","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1038\/onc.2013.107","article-title":"DDX3 loss by p53 inactivation promotes tumor malignancy via the MDM2\/Slug\/E-cadherin pathway and poor patient outcome in non-small-cell lung cancer","volume":"33","author":"Wu","year":"2014","journal-title":"Oncogene"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/7\/3483\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:41:39Z","timestamp":1760136099000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/7\/3483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,23]]},"references-count":145,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,4]]}},"alternative-id":["ijms23073483"],"URL":"https:\/\/doi.org\/10.3390\/ijms23073483","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,23]]}}}